Stephen McSorley

Dr. Stephen McSorley is a Senior Clinical Research Fellow at the School of Cancer Sciences and an Honorary Clinical Lecturer at the School of Medicine, Dentistry & Nursing at the University of Glasgow. He is based at the Glasgow Royal Infirmary and specializes in colorectal cancer surgery with a focus on minimally invasive techniques. His clinical work is closely integrated with his research activities, particularly in the areas of systemic inflammatory response and colorectal cancer outcomes.

Dr. McSorley's primary research interests center on the influence of the postoperative systemic inflammatory response on morbidity and long-term survival after surgery for colorectal cancer, as well as the early detection and prevention of colorectal cancer in both symptomatic and screened populations. His work spans several interconnected domains including robotic-assisted surgery, the gut microbiome, and the relationship between body composition and cancer outcomes. He has made significant contributions to understanding how surgical techniques (particularly minimally invasive approaches) affect the inflammatory response and how this relates to patient recovery and long-term outcomes.

Analysis of his recent publications reveals a consistent focus on the intersection of surgical technique, inflammatory response, and cancer outcomes. His work demonstrates a progression from basic understanding of inflammatory markers to their application in clinical decision-making, surgical technique optimization, and risk stratification. A significant portion of his research involves the INCISE (Integrated Technologies for Improved Polyp Surveillance) study cohort, which examines risk stratification for metachronous polyps after bowel screening polypectomy.

Dr. McSorley has been actively involved in mentoring junior researchers and clinicians through his role at the University of Glasgow, though specific students are not listed in the available documentation. His work appears to be supported by various research grants related to cancer surgery and inflammatory response, though specific funding sources are not detailed in the provided information.